Highbridge Capital Management’s AtriCure ATRC Stock Holding History

Highbridge Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,164	Closed	-$208K	–	913
2018 Q1	$208K	Buy	+10,164	New	+$184K	﹤0.01%	1050
2016 Q3	–	Sell	-30,641	Closed	-$433K	–	1300
2016 Q2	$433K	Buy	+30,641	New	+$467K	0.01%	903

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Highbridge Capital Management's ATRC Position: Q2 2018 in Review

Highbridge Capital Management sold out of AtriCure (ATRC) in Q2 2018, closing a stake of 10,164 shares — an estimated $208K sold.

Highbridge Capital Management first reported a position in ATRC in Q2 2016 and held it in 2 quarters. The position peaked at $433K in Q2 2016. 108 funds tracked by Wall St. Rank hold ATRC as of Q2 2018.

Highbridge Capital Management reported no remaining AtriCure position as of Q2 2018 after selling out during the quarter.
Highbridge Capital Management sold 10,164 AtriCure shares in Q2 2018, an estimated $208K.
Highbridge Capital Management first reported a position in AtriCure in Q2 2016 and held it in 2 quarters.
Highbridge Capital Management's AtriCure position peaked at $433K in Q2 2016.
108 funds tracked by Wall St. Rank held AtriCure as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.